Incentive processing in Congenital Adrenal Hyperplasia (CAH): a reward-based antisaccade study by Müller, Sven et al.
Running	  title:	  Incentive	  processing	  in	  congenital	  adrenal	  hyperplasia	  	  
	   1	  
Incentive processing in Congenital Adrenal Hyperplasia (CAH): a 
reward-based antisaccade study  
Sven C. Mueller1,2*, Teresa Daniele1, Jessica MacIntyre1, Katherine Korelitz1, 
Carlisi, Christina1, Michael G. Hardin1, Carol VanRyzin3, Deborah P. 
Merke3,4, Monique Ernst1 
 
1Section of Developmental and Affective Neuroscience, National Institute of 
Mental Health, Bethesda, MD, 20892, USA 
2Department of Experimental Clinical and Health Psychology, Ghent 
University, 9000 Ghent, Belgium  
3NIH Clinical Center, Bethesda, MD, 20892, USA 
4 Program in Developmental Endocrinology and Genetics, National Institute of 
Child Health and Human Development, National Institutes of Health, 
Bethesda, MD, 20892, USA 
 
 
 
 
 
 
*Corresponding author: 
Sven Mueller 
Dept. of Experimental Clinical and Health Psychology 
Ghent University 
Henri Dunantlaan 2 
9000 Ghent, Belgium 
Tel: +32 – 9 – 2648622 
Fax: +32 – 9- 2646489 
Sven.Mueller@UGent.be 
Running	  title:	  Incentive	  processing	  in	  congenital	  adrenal	  hyperplasia	  	  
	   2	  
Abstract 
Little is known about how steroid hormones contribute to the beneficial effect of 
incentives on cognitive control during adolescent development. In this study, 27 
adolescents with Congenital Adrenal Hyperplasia (CAH, mean age 15.6 years, 12 
female), a disorder of cortisol deficiency and androgen excess, and 36 healthy 
participants (mean age 16.3 years, 18 female) completed a reward-based antisaccade 
task. In this mixed-saccade task, participants performed eye movements towards 
(prosaccades) or away (antisaccades) from a peripherally occuring stimulus. On 
incentive trials, monetary reward was provided for correct performance, while no 
such reward was provided on no-incentive trials. Consistent with the hypothesis, the 
results showed that healthy, but not CAH adolescents, significantly improved their 
inhibitory control (antisaccade accuracy) during incentive trials relative to no-
incentive trials. These findings were not driven by severity of CAH (salt wasters vs. 
simple virilizers), individual hormone levels, sex, age-at-diagnosis, or medication 
type (dexamethasone vs. hydrocortisone). In addition, no significant differences 
between groups were found on orienting responses (prosaccades). Additional analyses 
revealed an impact of glucocorticoid (GC) dosage, such that higher GC dose predicted 
better antisaccade performance. However, this effect did not impact incentive 
processing. The data are discussed within the context of steroid hormone mediated 
effects on cognitive control and reward processing.  
 
Key words: inhibitory control, androgen, development, adolescence, sex steroids, 
testosterone, cortisol 
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Introduction 
Congenital Adrenal Hyperplasia (CAH), a disorder of cortisol deficiency with 
concurrent excess of androgen production (Merke and Bornstein, 2005), is a natural 
model to investigate the impact of early hormonal disturbances on cognitive and 
affective function. In addition to cognitive-behavioural deviances (Hines et al., 2003), 
perturbations in affective processing have been documented in these patients, both at 
the behavioural (Oner et al., 2009) and neural (Ernst et al., 2007; Mazzone et al., 
2011) level. For instance, CAH adolescents show abnormal activations of the 
amygdala, hippocampus, and anterior cingulate cortex in response to facial emotion 
(Ernst et al., 2007; Mazzone et al., 2011). However, at present, no studies have 
examined motivational processes in CAH, or how early steroid perturbations can 
affect these processes in the long term (Helleday et al., 1993). Together with emotion, 
motivation is a critical determinant of goal-directed behaviour, and can facilitate 
cognitive control by strengthening self-regulation.   
Indeed, studies report that motivation, by virtue of monetary incentive, can 
enhance cognitive control, particularly during development (Geier et al., 2010). The 
neurobiology of motivation implicates dopamine as a critical mediator of this function 
(Robbins, 2007). Despite evidence that links cortisol to dopamine function (Sanchez 
et al., 2000; Tsukada et al., 2011), little is known about how steroid hormones 
influence motivation and cognitive control (McGough et al., 2005). Such knowledge 
might be important in light of the higher incidence of mood and anxiety disorders in 
CAH youth compared to rates in the general population (Mueller et al., 2010a), which 
could be partly mediated by disturbances of motivational processes.  
An ideal paradigm to examine motivation and inhibitory control is the 
incentive antisaccade task (Mueller et al., 2010b). Antisaccades require the inhibition 
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of a ‘reflexive’ eye movement to a peripherally appearing stimulus (the prosaccade) 
and the generation of an eye movement to the opposite direction (the antisaccade). 
Developmental studies document reduced antisaccade performance in healthy 
adolescents relative to adults (Everling and Fischer, 1998; Fischer et al., 1997), but 
improvement in antisaccade accuracy with monetary incentives (Geier et al., 2010). 
By contrast, incentives do not improve antisaccade accuracy in mood-disordered 
adolescents (Mueller et al., 2010a) or adolescents with a history of neglect/abuse 
(Mueller et al., 2012).  
One clear advantage of using the antisaccade task is a well-understood 
neurobiology underlying eye movement behaviour. Task performance relies heavily 
on both the prefrontal cortex (dorsolateral PFC and the frontal and supplementary eye 
fields) and the basal ganglia (including the caudate nucleus and substantia nigra) 
(Munoz and Everling, 2004). It has been argued that the lower antisaccade accuracy 
in children compared to adults reflects the protracted development of the prefrontal 
cortex (Luna et al., 2001) and an associated difficulty in inhibiting pre-target activity 
in saccade neurons, which helps to suppress  reflexive prosaccade responses (Munoz 
and Everling, 2004). However, evidence of how steroids alter the antisaccade system 
during development is lacking.  
This study aimed to identify, in CAH patients, potential abnormalities in the 
motivational modulation of inhibitory control using monetary incentives during a 
validated oculomotor task. We sought to assess the integrity of motivational processes 
and their influence on cognitive control in CAH, and by inference, the potential long-
term effects of early steroid disruption on these processes. Based on previous findings 
(Mueller et al., 2010a), we predicted that healthy participants, but not patients with 
CAH, would show improvement on inhibitory control during incentive relative to no 
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incentive trials. No significant differences would be expected during lower cognitive 
level processes, such as attentional orienting responses (prosaccade trials).  
 
Methods 
Participants 
Twenty-seven adolescents with classic CAH (mean age 15.61 years ± 3.96 SD, 12 
female) and 36 healthy participants (mean age 16.26 ± 5.67 SD, 18 female) completed 
the task. Of the CAH, 16 patients had the salt wasting (SW) form, while 11 had the 
simple virilizing (SV) form. The groups were similar on age (F(1,61)=0.26, p=.61), 
but differed on IQ (F(1,61)=5.48, p=.02), which was  higher in the healthy group 
(mean = 115.72 ± 11.06 SD) than the CAH group (mean = 108.52 ± 13.34 SD). 
Consequently, IQ was used as a covariate of no interest in all subsequent analyses. 
There were no significant group differences in state anxiety (F1,61)=2.36, ns), trait 
anxiety (F(1,61)=0.34, ns), or level of depression (F(1,48)=0.15, ns). Healthy 
participants were recruited through fliers and newspaper advertisements. Patients with 
CAH were enrolled as part of a Natural History Study at the NIH Clinical Center in 
Bethesda, Maryland, USA (Clinical Trial No. NCT00250159). The study was 
approved by the IRB of the NIMH and National Institute of Child Health and Human 
Development. Parents provided written informed consent and minors written assent. 
All participants underwent neurologic and psychiatric evaluation, physical 
examination, and IQ testing.  In addition, all patients underwent thorough clinical and 
endocrinological evaluation and all classifications were confirmed by genotype. All 
patients were on glucocorticoid medication at the time of testing (hydrocortisone: n = 
19; dexamethasone: n = 7, prednisone: n = 1). Five of the CAH patients suffered from 
co-morbid psychopathology (2 ADHD, 2 anxiety disorder, 1 substance abuse). Nine 
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(33.3%) patients had elevated 17-hydroxyprogesterone levels; but all had normal 
testosterone values for age and sex.  
 
Apparatus  
Saccades were recorded using a remote mounted eye tracker with a 240 Hz 
sampling rate (Applied Science Laboratories; ASL Inc., Bedford, MA). Participants 
were required to either make an eye movement towards (prosaccades) or away 
(antisaccades) from a white target asterisk that was subtending 0.5 deg in visual angle 
(Figure 1). Each eye movement was paired with one of three incentive conditions. 
Prior to the target, a cue (‘+’,  ‘-‘, ‘0’) indicated the type of incentive and the type of 
saccade participants had to perform. If the color of the cue was grey an antisaccade 
was required. If it was white, participants had to execute a prosaccade. During the 
reward condition a ‘+’ sign indicated that participants could win $1 if they executed a 
correct eye movement, in the punishment condition a ‘-‘ sign indicated that they 
would lose $1 for an incorrect eye movement, and in the no-incentive condition a ‘0’ 
indicated no gain or punishment regardless of whether the eye movement was correct 
or incorrect. To examine potential differences in the effects of valence on 
performance, statistical analyses directly compared the reward and punishment on 
measured of latency and accuracy. As valence showed no significant effects 
(t(62)=0.12, ns), and to increase statistical power, positive and negative incentives 
were pooled together for the main analysis. Participants were given immediate 
feedback as to whether they had won $1 (displayed in green) or lost $1 (displayed in 
red).  
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****************** FIGURE 1 ABOUT HERE PLEASE ****************** 
 
 
Procedure 
Adolescents were seated in a chair about 66 cm away from the screen in an 
illuminated room and completed 3 runs of 48 randomly intermixed trials (= 144 total). 
Subjects started with $0.00 and could win up to $4.80 per run. In-between runs, 
participants’ eye movements were re-calibrated if necessary. A chin-rest was used to 
minimize movement. Afterwards, participants were sent a check for the amount of 
their winnings.  
 
Statistical analysis  
Saccade accuracy (percent of trials that were errors) and latency (response 
time of correct responses in ms) were analysed. Correct saccades were defined by 
their direction and latency with a threshold criterion set at 30 deg/sec. Anticipatory 
(latency < 80 ms) or late (latency >700 ms) saccades were excluded from analysis. 
Each saccade parameter was entered separately into a three-way repeated measures 
analysis of variance (ANOVA), with group (Healthy vs. CAH) as the between-
subjects factor and saccade type (prosaccades [PS] vs. antisaccades [AS]) and 
incentive (incentive vs. no-incentive) as the within-subject factors. Post-hoc analyses 
were used to examine the potential impact of medications, or comorbid illnesses. 
Correlations (r) were conducted to examine associations between saccadic 
performance and hormone levels (which were taken at 0800h and before medication). 
To ensure that findings were not confounded by comorbid illnesses, sex, or CAH 
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severity, the main analyses were repeated accounting for these differences. Finally, 
the impact of glucocorticoid (GC) exposure and duration of untreated 
hypocortisolemia and androgen excess were also assessed. For GC exposure, we 
calculated the hydrocortisone equivalency doses (mg/m2/day; Hindmarsh, 2009; 
Rivkees and Crawford, 2000) and included this factor as an additional covariate. For 
the duration of untreated hypocortisolemia and androgen excess, we examined age at 
diagnosis in the simple-virilizing group (patients with the salt-wasting form could not 
be used since they are identified at birth and immediately treated).  
 
****************** TABLE 1 ABOUT HERE PLEASE ****************** 
 
Results 
Accuracy 
As predicted, the three-way Saccade-type by Incentive by Group interaction was 
significant (F(1,60)=5.29, p<.05). To determine the directionality of the interaction, 
we conducted 2 two-way ANCOVAs, one for each group. In the healthy group, the 
Saccade-type by Incentive interaction was significant (F(1,35)=16.89, p<.001). 
Follow-up t-tests revealed that the incentive effect was only significant for AS 
(t(35)=-3.32, p<.01) but not PS (t(35)=0.89, p=.38).  By contrast, in CAH, the 
Saccade-type by Incentive interaction was not significant (F(1,26)=0.08, p=.79). 
 
A main effect of Saccade-type, as expected, showed that all participants elicited fewer 
errors on PS than AS (F(1,60)=5.38, p<.05), a finding that also emerged in the follow-
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up analyses of the 2-way interactions for both healthy (F(1,35)=124.61, p<.001) and 
CAH (F(1,26)=121.04, p<.001) groups.  
 
Latency 
A main effect of Saccade-type, as expected, revealed significantly faster PS than AS 
(F(1,60)=4.89, p<.05). The three-way interaction of Group by Saccade-type by 
Incentive was not significant (ns).  
 
Additional analyses 
Correlations with hormonal levels in CAH  
No significant correlations of hormone levels were observed with differences between 
incentive and neutral trials in measures of accuracy or latency (testosterone: all 
r(27)<.18, ns; 17-hydroxyprogesterone: all r(27)<.21, ns).  
 
 
Impact of CAH severity, sex, medication type, glucocorticoid dose, age at diagnosis, 
or psychiatric co-morbidity 
Additional analyses comparing performance in salt-wasters (n=16) and simple 
virilizers (n=11) did not reveal any significant main effects of CAH type or 
interactions with incentive or saccade type (all p >.05). Analyses of sex effects in the 
CAH group (15 males, 12 females) did not reveal any significant differences in 
relation to incentive, neither for latencies (p =.53) or accuracy (p=.79). No other 
findings were significant. A regression analysis comparing the potential impact of 
medications (dexamethasone vs. hydrocortisone) did not reveal any significant effects 
for either saccade accuracy (all p >.45) or latency (all p >.17) on incentive or no-
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incentive trials. However, when we assessed the impact of glucocorticoid dose 
(hydrocortisone equivalency dose), a significant interaction between saccade type and 
glucocorticoid dose emerged (F(1,25)=6.49, p<.02). To further examine the 
directionality of this interaction, correlations between glucocorticoid dose and 
prosaccade and antisaccade accuracy were performed. These correlations revealed 
that antisaccade error rate correlated significantly with equivalency rate (higher GC 
dose = lower error rate) (r(27)=-.40, p=.038) but had no effect on prosaccade error 
rate (r(27)=.14, p=.49). Furthermore, the difference between these two correlation 
coefficients was marginally significant using the Fisher r-to-z transform (p=.05). No 
other effects were significant. To assess to what extent the duration of untreated early 
steroid perturbation may have influenced the findings, we examined age-at-diagnosis 
as a potential variable of interest in the simple virilizers of the sample (N=11). These 
limited analyses did not reveal any effects (all p>.42). Finally, when the 5 CAH 
adolescents with a current psychiatric diagnosis (2 ADHD, 2 anxiety disorder, 1 
substance abuse) were excluded, CAH still failed to show a significant effect of 
incentive (p=.38) or incentive by saccade-type interaction (p=.57). These findings 
suggest that psychiatric co-morbidity is not responsible for lack of sensitivity to 
incentive.  
 
Discussion 
This study investigated the impact of prenatal steroid disruption on cognitive 
control and motivation. As predicted, inhibitory control was improved (increased 
antisaccade accuracy) during incentive conditions relative to no-incentive trials in 
healthy adolescents, but not in patients with CAH. These results suggest that early 
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disturbance of the hormonal milieu in CAH may disrupt the mechanisms by which 
motivation can improve voluntary action.  
Importantly, consistent with prior neuropsychological data in CAH adults 
(Malouf et al., 2006), the CAH group did not evidence general impairments of 
cognitive control (AS) or attentional orienting (PS), i.e., no performance differences 
between CAH and comparisons. These findings suggest that early hormonal 
dysfunction appeared not to have detectable long-term effects on basic inhibitory 
control or attentional orienting. Therefore, the current findings imply specific 
hormonal modulation of the impact of motivational processes on inhibitory function. 
The prefrontal cortex and striatum play an essential role in cognitive control 
(Robbins, 2007). Moreover, the interplay between these two regions has been 
implicated in the development of motivated behaviour (Ernst and Fudge, 2009). 
Interestingly, cortisol binds to dopamine receptors in both prefrontal cortex (Lataster 
et al., 2011; Mizoguchi et al., 2008b; Sanchez et al., 2000; Tops et al., 2006) and 
striatum (Tsukada et al., 2011; Wand et al., 2007)  possibly mediating dopaminergic 
influences on motivational and regulatory processes. The current findings elicit novel 
hypotheses regarding early, organizational influences of sex steroid perturbations on 
the developmental trajectories of systems mediating inhibitory control and reward. 
For example, one question is whether early steroid deficiency alters striatal feedback 
mechanisms into the PFC, which are aimed to increase cognitive control during 
motivated behaviour. 
Although a hallmark symptom of CAH is cortisol deficiency (Merke and 
Bornstein, 2005), an interesting alternative explanation is a potential role of excess 
androgen in the present findings (Aubele and Kritzer, 2011). A recent developmental 
fMRI study documented significant correlations between testosterone levels and 
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striatal activity during a monetary incentive task (Op de Macks et al., 2011). 
Conversely, boys suffering from androgen excess showed significant volumetric 
alterations in the striatum, which correlated with testosterone levels (Mueller et al., 
2011). These data might suggest a mediation of motivational mechanisms by 
androgens.  
Some limitations of the study deserve discussion. Certainly, a limitation of this 
study is that it cannot distinguish between the distinct effects of specific steroid 
hormones due to feedback loops involving both sex steroids and corticosteroids. 
However, natural models of steroid dysfunction, such as CAH, can aid in the 
formulation of research hypotheses for studies in animal models (Mizoguchi et al., 
2008a; Steimer et al., 2007) or healthy volunteers (Tops et al., 2006).  Another 
limitation concerned medication use in all patients. Although we did not find a 
differential effect of medication type, current glucocorticoid dose correlated with 
antisaccade performance in the post-hoc analyses. As this correlation suggested 
improved antisaccade accuracy with higher GC dose, a negative impact due to supra-
threshold levels of GC seems unlikely. However, as inhibitory control and incentive 
processing are two distinct processes, future studies could more directly examine their 
sensitivity to GC modulation. To examine the extent to which the duration of 
untreated cortisol deficiency/androgen excess could have impacted the findings, age 
at diagnosis in the simple-virilizing group, for whom time of diagnosis and initiation 
of treatment varies, was taken into consideration. Although no effects were found, any 
negative findings must be interpreted with caution due to the small number of patients 
with the SV form. Future studies could more specifically investigate developmental 
effects of steroid exposure by examining other patient groups for whom cortisol 
perturbations develop later in life, such as Cushing disease (Starkman et al., 1992). In 
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summary, this is the first study, to our knowledge, that demonstrates motivational 
deficits in CAH as evidenced by the rewarded antisaccade task.  
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Captions 
Figure 1. Stimuli were presented on a black background (for clarity of presentation, 
colour schemes are reversed in the figure). Each trial started with the cue, which was 
presented for 1250 - 1750 ms and which indicated the type of incentive and the type 
of saccade, both of which were randomized. Once the cue disappeared, the white 
target asterisk was displayed for 1850 ms on either the left hand or right hand side 
approximately 6.15 deg to the centrally presented cue. Then, the feedback display 
(subtending ~1.8 deg in visual angle) was presented for 1000 ms on the side where 
the correct eye movement should have occurred. This sample trial shows a rewarded 
antisaccade, where the cue (“+”) indicated the reward and an antisaccade was 
correctly executed to the left.  
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Table 1. Latencies and accuracy rates for both groups for the different conditions. 
BOLD font indicates significant three-way interaction (p<.05).  
 	   	   Antisaccade	   	   Prosaccade	   	  	   	   CAH	   Control	   CAH	   Control	  
	   	   	   	   	   	  
Accuracy	  	  
(%	  error,	  SD)	   Incentive	   46.76	  (11.68)	   40.79	  (17.36)	   19.59	  (10.66)	   17.88	  (9.02)	  	   No	  
incentive	  
47.54	  
(14.07)	  
48.38	  
(15.69)	  
21.14	  (12.55)	   16.55	  (8.99)	  
	   	   	   	   	   	  
Latency	  	  
(ms,	  SD)	   Incentive	   298.57	  (94.60)	   280.83	  (75.65)	   306.69	  (103.60)	   249.36	  (100.83)	  	   No	  
Incentive	  
335.98	  (170.46)	   295.55	  (110.82)	   308.82	  (100.11)	   275.86	  (138.47)	  	  
 
